<DOC>
	<DOCNO>NCT02357537</DOCNO>
	<brief_summary>This study design assess difference remote on-site patient study participation State Massachusetts , well significance dietary intervention impact UC . The study activate one site Principal Investigator utilize subject 's local care system ( local Gastroenterologist ) collect study data , along telemonitoring video visit , make key study assessment decision regard subject ' progression study .</brief_summary>
	<brief_title>Decentralized Dietary UC Pilot Trial</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>1 . Males female age 18 80 , inclusive , reside state Massachusetts . 2 . Ability willingness provide document informed consent comply study procedure , include inperson visit Arm 1 video visit Arm 2 . 3 . Documented history moderate severe active UC 4 . Disease duration ≥12 week time screen ( diagnose accord American College Gastroenterology practice guideline ) 5 . Screening fecal calprotectin &gt; 350 mg/g 6 . Diagnosis moderately severely active UC , include historical endoscopy sub score ≥2 ; rectal bleeding sub score ≥1 disease activity minimum 25 cm anal verge . 7 . Documented ( via video report ) endoscopy perform within 2 year prior randomization . 8 . Access computer mobile device internet connection active email address . 1 . Prior extensive colonic resection , subtotal total colectomy plan surgery UC 2 . Past present ileostomy colostomy 3 . Short bowel syndrome 4 . Diagnosis indeterminate colitis , fulminant colitis , toxic megacolon 5 . Past present fistula abdominal abscess 6 . History current evidence colonic mucosal dysplasia 7 . Use tube feeding , define formula diet parenteral alimentation/nutrition discontinue ≥3 week prior study enrollment 8 . Use anticoagulant , herbal supplement omega3/fish oil supplement study 9 . Crohn 's Disease 10 . Significant uncontrolled comorbidity , neurological , cardiac ( e.g. , moderate severe heart failure NYHA class III/IV ) , pulmonary , renal , hepatic , endocrine gastrointestinal disorder 11 . History alcohol , drug chemical abuse within 6 month prior screen 12 . Pregnant female , intend become pregnant , lactate 13 . Current participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Telemedicine</keyword>
</DOC>